Can Pitolisant-wakix cure narcolepsy?

Pitolisant (Pitolisant)-wakix is the last drug on the market to treat narcolepsy. It has shown improvements in reducing drowsiness and fewer side effects than usual medications. A review of these studies concluded that tilolixen tablets were superior to placebo and non-inferior to modafinil in improving excessive daytime sleepiness (EDS). Another advantage of tilorisen tablets is its potential for slow abuse. Overall, this drug shows significant efficacy with low abuse potential compared to other drugs.

Narcolepsy is a sleep disorder characterized by chronic, debilitating excessive daytime sleepiness and may be associated with cataplexy, sleep paralysis, and sleep-related hallucinations. In addition to physical symptoms, patients often experience a reduced quality of life, with daytime sleepiness affecting their ability to socialize and be productive at work. The main goals of pharmacological treatment of narcolepsy are to increase arousal and reduce cataplexy episodes. Tilolixen tablets can help improve wakefulness and concentration and reduce symptoms of daytime sleepiness. However, it does not completely cure narcolepsy. This drug is mainly used to control symptoms and reduce patients' feelings of daytime sleepiness and sleepiness.

If a patient is diagnosed with narcolepsy, it is recommended to consult a professional physician for detailed diagnosis and treatment recommendations. Everyone's condition is different, and the doctor will develop the most appropriate treatment plan based on the patient's specific situation. Tilolisan tablets are already on the market in the country, but have not yet been included in medical insurance. The price of each box of the original version of tilorisen tablets marketed overseas may be over more than RMB 4,000 (the price may fluctuate due to exchange rates). Currently, there are no generic versions of tilorisen tablets produced and marketed overseas.